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Results are ahown above for both the training (solid line) and validation
(daahed line) sets. Figure 1: Applying the CLIN model, two yr event free
survival was 95+ 1%, 66 + 2%, and 61 +9% for the training set and 93 +
3%, 69* 3%, and66 + lo’% forthe validation setateach estimated risk level.
Figure Z: Applying the CLIN + dipyridamole thallium model; two yrevent free
suwival was 96 + I%, 66 & 2%, and 66 + 8% for the training set and 96
+ 2%, 66 + 3%, and 66 + 10% for the validation set at each eatimatad risk
level. Corrc/usiorrs.’Both long-term prediction models can reliably estimate
the risk of a cardiac event in both the training and validation sets and are
thus generalizable to the vascular surgery population
1057-8 Montreal Heart Attack Readjustment Trial
(M-HART): A Randomized Trial of Psychosocial
Intervention Following Ml
N.Fr&sure-Smith, F. Lesp6rance, R. Prince, P.Verrier, M. Juneau,
M. Bourassa. Morrtraal Heart Institute and McGi// UniveraiV, Montreal,
Quebec, Canada
Research has linked psychological distress with an increased risk of mortality
following myocardial infarction (Ml), but there have been no large, random-
ized trials in this area. M-HART was the first large trial to attempt to alter the
risk. Between 1991 and 1994, 1376 pts (473 women), aged 27 to 87, were
randomized to 1 year of treatment (T; n = 692) or usual care (C; n = 664). T
pts were phoned monthly to assess distress; distressad pts received home
nursing visits. Over the year, 3/4 had elevated distress on at least one call
and received an average of 6 one-hour home visits. Under the supervision
of psychiatrists, nurses with catrliac experience provided individually tailored
combinations of education, suppo~ and referral to other health resources.T
and C groups were balanced on background and cardiac disease factors
There were65 deaths (56 cardiac). Cumulative survival was compared using
Cox proportional hazards regression. There was no overall treatment impact
on mortality (Hazards Ratio for T (HR) = 1.40; 95% Cl = 0.85-2.29; p =
0.18), and no impact among men (HR = 0.97; Cl = 0.46-2.03; p = 0.93).
Surprisingly, women receiving treatment were marginally more likely to die
than those in usual care (HR = 1.94; Cl = 0.99-3.60, p = 0.055). Control for
Calliope class, age, left ejection fraction and beta-blockade did not alter re-
sults. T-related changes in anxiefyldepression scores among survivorawere
small. tn this randomized trial of intewention to reduce distress in post-Ml
patients, there was no evidence of overall benefit and suggestion of potential
harm for women.
D10579 Probability of Being Employed 2 Years AfterMyocardial Infarction
A.M. Ross, W.F. McCarthy, C.A. Fink, P.L.Walker, J.S. Reiner,
C.F. Lundergan, K.S. Coyne. The George Washington llriversi~
Washington, DC, USA
We evaluated baseline clinical and post-lytic angiographic variables that
might relate to the probability of ‘patients returning to full-time employment
(FTE) after myocardial infarction (Ml). The population consisted of GUSTO
I angicgraphic patients fully employed preceding the Ml (n = 696). The
outcome variable was return to FTE. The predictor variables were: age (p
= 0.0001), gender (p = 0.0121), convalescent ejection fraction (EF) (p =
hrerican,Age40
Non-Amdcan,Age40
American,Age55
Non-Anrerican,Age55
0.0291), and American (Am) vs. non-American (p= 0.0001). Other variablea
considered but not significant were: race, Iytic agent, hypertension, and
diabetes. Representad graphically is the probability of returning to FTE (a =
Am, age 40; b = non-Am, age 40; c = Am, age 55; d = non-Am, age 55). For
example, at age 55 and EF 40%, an Am male has a 0.62 probability of return
to FTE compared with 0.45 for non-Am males; 0.44 for Am females, 0.28 for
non-Am females. For an EF of 50%, the probabilities are 0.66, 0.49, 0.47,
and 0.31 respectively.
Cone/usiorr: Nationality, gender, and the physiologic response (EF) to
reperfusion therapy can ba added to factors recognized as influencing post-
MI return to work (such as age, education level, etc.).
[-] -SignificanCeOf burId,ebranchb,ockafter
myocardial infarction in the thrombolytic era
P.A.Doevendans, A. van den Dool, L. Konst, E. Cheriex, H.J. Wellens.
Department ofcardio/ogy Academic Hoepita/ Maaatrfcht, the Netherlands
Many studies on the efficacy of thrombolytic therapy and risk-stratification
after acute myocardial infarction (AMI) exclude pts with a QRS <120 msec.
In a prospective study during a two year period from 1990 until 1992,431 pts
with an acute myocardial infarction were enrolled. 24 Hours after admission
pts were grouped as having either bundle branch block (BBB) ornarrow QRS
(S 120 maec).
Methods: BBB was defined by QRS duration >120 msec on the 12 lead
ECG. When possible the ECGS were compared to registrations obtained
before admission. The left ventricular ejection fraction (LVEF) waa measured
by echocerdiography.
Resuk During admission 19/431 (4.4%) pts died. After discharge 9/412
(2.2%) pts sufferad a cardiac death, during 12 months follow up (FU). BBB
was present in 34 patients. The BBB was preexistent in 18 pts, unknown in
6 while 10 pts developed a new BBB.
n Thrombolytic LVEF III hospital Death during
thORIDV < 400/. death fO1lOWUD
. .
QRS 5120 msec 397 204 (51%) 95 (24%) 15 (4%) 6/382 (2%)
New BBB 10 6 (60°/0) 8 (60%) 4 (40°/6) 0/6
PreexistentBBB 16 4 ~22%j a &4%j o‘ 3/18 (17%)
Unknown 6 2 (33”/.) 1 (17%) o 0/6
p value NS <0.05 <0,05 <0,05
Conclusion: Pfs showing BBB 24 houra after AMI have more often im-
paired left ventricular function then pts with narrow QRS. The pts with a new
BBB are at increased risk for in hospital death (40 versus 4%). Pts with a
preexistent BBB have a worse prognosis following discharge (17 veraus 2%)
and receive thrombolytic therapy less frequently.
D105711 Benefit of Previous Angina on In-hospital Survival
and No Benefit on Long-term Survival
Y.Kobayashi, S. Miyazaki, Y. Miyao, L Morii, T. Matsumoto, S. Daikoku,
A. Itoh, Y. Goto, H. Nonogi. National Cardiovascular Centec Osaka, Japan
TIMI 4 trial showed that previous angina (AP) conferred a beneficial effect
on in-hospital outcome after acute myocardial infarction (Ml). The present
study evaluated the long-term prognosis between patients with and without
AP before Ml. A total of 1,322 petienta admitted due to acute Ml between
1980 and 1969 were dividad into 3 groups according to the following status
of AP before Ml; 1) no AP, 2) stable AP, and 3) unstable AP. Follow-up data
were available for 1,310 (99%) patients. The mean follow-up period was 7.5
+ 2.0 years. The in-hoapital mortality rate was lower in patients with stable or
unstable AP than in those without AP (p < 0.01). In contrast, in the follow-up
for hospital survivors, cardiac death (p< 0.01) and cardiac events (p< 0.01)
wera higher in patients with stable AP than in those with no AP or unstable
AP.
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Mukivariate analysis showed that age, Killip claas, multivessel disease,
prior Ml, heart rate at admission, and ejection fraction were independent
predictors of cardiac death. Thua, the present study revealed that, although
JACC February1997 ABSTRACTS-Poster 453A
APbefors Ml improves in-hospital outcome, itaffords no benefit once patients
left the hospital.
11057-12]AdmiSSiOnStanda~dECGf~~Ea~lY*i~k
Stratificationin PatientawithUnetablaCoronary
ArteryDiaeaes- A TRIMaubatudy
L. Holmvang, P.Clemmensen, G. Wagner, P.Grande for the TRIM Study
Group. The Heed Centec The National University Hospital, Copenfregen,
Denmark, Duke University Medical Center, Durham, NC, USA
Unstable coronary atiefy disease, i.e. non-Q myocardial infarction and unsta-
ble angina pectoris represent a heterogeneous population of patients; some
at high risk of cardiac morbidity and mortality. The purpose of the present
study was to determine the prognostic value of risk stratification based on a
single admission ECG in patients with this syndrome.
Mehxfa.’ 472 patients from the TRIM study were included. All patients
were admitted within 24 hours of chest pain onset and treated with iv. anti-
thrombotic therapy for 72 hours after inclusion. Data: The patients were
divided into four subgroups based on the ST-segment changes in the inclu-
sion ECG: 75 (16%) had ST-elevations (with or without T-wave inversion),
59 (13%) had ST-depression (with or without T-wave inversion) 199 had iso-
lated inverted T-waves (42%) and 139 (29%) patients had no ST-changes.
Endpoints: Death, Ml, refractow angina (despite of treatment) or recurrent
angina pactoris was registered during a follow-up period of 30 days.
Raaulta: The total number of patients suffering an event was 247 (52%).
Fifty-one of these patients (11%) had a serious event (death, Ml or refractow
angina). Seventy percent of all events occurred within 72 houra after inclu-
sion. Patienta with STdepression had the highest event rate and patienta
with ST-elevation had the lowest event rate, although the event rate among
patienta with ST-elevation did not differ significantly from the patients with
no-ST-changes in the baseline ECG. The difference in event rates between
patienta with ST-depression and patients without ST-cfepressionin the base-
line ECG was highly significant (p =0.003, log rank test). A separate analysis
regarding serious cardiac events was performed, revealing a similar signifi-
cantly increased event rate among patients with ST-depression (p= 0.0003).
PatientswithST-depression at baseline hadariskof 24% forhavin98 serious
cardiac event during follow-up compared to 11%in the entire population.
Conclusion: Standard ECG ST- segment depression at inclusion were
significantly associated with increased risk of early cardiac events in patients
with unstable coronary artery disease. On the contrary, ST-elevation in this
population not undergoing thrombolytic therapy, was associated with a good
prognosis.
n1058 Refractory Angina and End-Stage CoronaryArtery Disease
Wednesday,March 19, 1997, Noon-2:O0p.m.
AnaheimConventionCenter,HallE
PresentationHour:Noon-1:00p.m.
D10581 HemodynamicBenefitof Long-termIntermittentUrokinaeeTherapyinEnd-ategeCoronaryArtery
Diaeaee- FiretReeultafroma GatedBloodPool
Study
B. Holz, F.C.Schoebal, T.W.Jax, P.Stark, E.G. Vester, M. Leschke,
B.E. Strauer. Department for Cardiobgx Heinrich Heine University of
DUaaeldorf,Germany
Background: Long-term intermittent urokinase therapy (UK) due to rhao-
Iogic and thrombolytic efficacy is an effective antiischemic approach for the
treatment of patients with end stage coronary artery disease and severe
angina pactoris refractory to conventional treatment. The impact of this form
of therapy on hemcdynamic parameters has not been investigated so far.
Metffoda: In a blinded study we investigated 25 patients before and after
Iong-tenmintermittent urokinase therapy (3 x 500,000 W urokinase iv. per
weak over 12weeks). All underwent a symptom-limited bicycle stress testing
with comparable level of exercise before and after treatment in combina-
tion with a gatad blood pool (GBP) analysis of left ventricular function. For
assessment of hemodynamic parameters the following were measured left
ventricular ejection fraction (EF), early systolic function (ESF) by peak ejec-
tion rate (PER)and early diastolic function (EDF) by peak filling rate (PFR)
at rest and under maximum exercise capacity.
Resu/ts: Clinkal symptoms were significantly reduced from 20.3& 5.4 to
7.2 + 2.8 angina eventa/week as well as fibrinogen levels from 338 + 43 to
207 +20 mg/dl. Hemodynamic parameters changed as follows.
Rest EF Max. EF Rest PER Max, PER Rest PFR Max, PFR
Before UK 41,2 + 14.7 43.3+ 17.5 1.9+ 0.8 2,0+ 0,9 1.5+ 0.6 2.3+ 0.9
After UK 43,8 + 14.9 52,8+ 16.7 2.3+ 0.7 2.6+ 1.1 2.2+ 0.6 3.0+ 1.3
Significance n,s. p ~ 0.01 p s 0,01 p s 0.05 p ~ 0.001 p ~ 0.01
Cone/usion:These results demonstrate that antiischemic effectiveness of
long-term intermittent urokinase therapy is also reflected by an improvement
of systolic and diastolic parameters of left ventricular performance in patients
with refractory angina pectoris.
m Lefiventri.u,ar~aviW~i.epredi.taTimecOUr*
of RecoveryofSystolicFunctionAfter
Revaacularizetion
M.J. Williams, B. Lytle, T. Marwick. Cleveland C/inic Foundation, C/eve/and,
OH, USA
In pts with left ventricular(LV) dysfunction thetimecouraeof LVrecovety after
revascularization (RVS) is unclear. We sequentially studied LVfunction in 45
pte with severe LVdysfunction (LVEF < 35%) who underwent complete RVS
without associated valve surgery. All pts underwent resting echo pra-RVS,
earfy (2.1 + 0.9 W) and late (21 + 10 W) post-RVS. LV end-diastolic volume
(EDV), end-systolic volume (ESV) and LVEF were calculated in apical 4 and
2 chamber views using Simpson’s rule. Significant recovery of LV function
was defined as > 5% improvement in LVEF post RVS.
Resu/ta: No recovery in LV function at either early or late echo was
reportad in 16 pts (40%). These pts had a larger pre-RVS LVEDV than those
showing recovery (196 + 53 vs 161 + 40 ml, p = 0.04), but there were no
differences in clinical variables between the groups. No pt with LVEDV =-230
ml recoveredfunction. Pts who sfrowed recovery of LVfunction (n = 27) were
divided into pts who showad earfy recovery sustained at late follow-up (n =
16,36%) and pts who showed only late recovery(n = 11,24%). Pts with earty
recovety had a significantly smaller csvity eize than those who recovered
late:
Early recovey Lete recovery p value
Age (y) 61 +9 62& 7 P = NS
pre-RVS LVEF (ml) 27.8& 3,8 24.7 &4.7 p = 0.09
pre-LVEDV(ml) 134+24 200 +29 p <0.0001
Conclusion: Pts with severe LV dysfunction and large LVEDV are less
likely to recover systolic function after RVS than thoee with emaller heark..
However, pta with large LVEDV may show late recovery of syetolic function
and late follow-up is warranted.
l-] Abnorma,cardiacsYmPathetic~erveFunctionin
PatienteWithSyndromeX
G.A. Lanza, A. Giordano, C. Pristipino, M.L. Calcagni, G. Maduri, C. Trani,
F. Crea, L. Troncone, A. Maseri. University’ Catto/ica, Roma, Italy
Previous work has suggested that cardiac adrenergic activity maybe abnor-
mal inpatients (pts)with syndrome X (SX, angina, STdepression on exercise,
normal coronary arteries). We assessed cardiac sympathetic nerve function
by pe~oming lzsl.metaiodobenzylguanidine (MIBG) myOCSKfialecintigraphy
in 12 SX pte (52 & 9 years, 5 men) and 10 healthy controle (53 + 5 years, 4
men). Radionuclide images were acquired 3 houra after iv. infusion of 5 mCi
(185 MBq) of MIBG. Global cardiac MIBG uptake was aseessed on planar
images by the hearUmediastinum(H/M) ratio, and a MIBG uptake ecore was
obtained from SPECT images. To this aim, the left ventricle was divided into
24 segments, an uptake score was assignad to each segment (O= normal
uptake to 3 = uptake < 50% of maximum), and total MIBG uptake score wae
obtainad as the sum of all segmental scores. On vieual inspection, an inferior
MIBG defect was only ob.sewed in 1 control subject (10%), while 9 SX pts
(75%, P < O.Ol),showed defects in MIBG uptake. Cardiac MIBG uptake was
totally absent in 4 pts, and regional defects were shown in other 5 pts, 4 of
whom also had reduced global uptake. H/M ratio was lower (1.7 +0.6 vs 2.2
+0.3, P= O.03),and MIBG uptake smre higher (35 + 31 VS4 & 2, P= O.003)
in SX pte. The Iunglmadiaetinum ratio of MIBG uptake was eimilar in the 2
groupa (1.36+ 0.2 vs 1.35 +0.2), suggesting that MIBG abnormalities were
confined to the heart in SX pts. Thus, our findings demonstrate abnormalities
in cardiac adrenergic newe function in most SX pts. These abnormalities
may contribute to several abnormal features report6d in these pta, including
coronary microvaecular dysfunction and abnormal cardiac pain sensitivity.
